Page 212 - Read Online
P. 212
Page 12 of 15 Rodrigues et al. Vessel Plus 2024;8:10 https://dx.doi.org/10.20517/2574-1209.2023.109
Table 2. Thoracoabdominal F/B-EVAR - Early outcomes
Respiratory Temporary Permanent Any GI HLOS
Author Year n Extent MAE Death AKI Dialysis MI SCI
failure paraplegia Paraplegia Stroke resection (days)
[63]
Oikonomou et al. 2019 71 - 13 (18,3) 4 (5.6) 2 (2.8) 2 (2.8) - - 11 9 (12,7) 2 (2.8) - - 11 (6-48)
n (%) or mean (± SD) (15.5)
[64]
Law et al. 2019 20 - - 1 (5) 5 (25) - 3 (15) - 2 (10) 1 (5) 1 (5) - - 9 (± 13)
n (%) or mean (± SD)
Motta et al. [61] 2019 150 - 39 (26) 4 (2.7) 7 (4.7) 2 (1.3) 10 (7) 1 4 (2,7) 1 (0.7) 3 (2) 1 (0.7) - 5.6 (± 5.4)
n (%) or mean (± SD) (0.7)
Rocha et al. [59] 2020 2,059 - - (7.4) (11.7) (6.4) - - (13.5) - (5.2) (2.7) - 12.8
(%) or mean (± SD) (7,8-17,7)
[62] IV (132) 30 (23) (1.5) 24 (18) 3 (2) 4(3) 6 (5) 3 (2) 2 (2) 1 (1) 4 (3) 2 (2) 6.1 (± 4.6)
Oderich et al.
n (%), (%) or mean 2021 430 I - III (165) 34 (21) (0.6) 18 (11) 3 (2) 7 (4) 1 (1) 20 (12) 13 (8) 7 (4) 5 (3) 0 (0) 9.6(± 10.7)
(± SD)
PRA (133) 19 (14) (0.8) 14 (11) 2 (2) 1 (1) 11 (3) 2 (2) 0 (0) 2 (2) 1 (1) 4 (3) 4.8 (± 5.4)
Zettervall et al. [65] 2022 1,681 I-III (644) 423 46 (3) 161 25 (2) 56 (3) 35 (2) 120 (7) 81 (5) 39 (2) 32 (2) - 6.8 (± 9)
US ARC IV (535) (25) (10)
n (%) or mean (± SD) CAAA
(502)
MAE: Major adverse events; AKI: acute kidney injury; SCI: spinal cord injury; MI: myocardial infarction; GI: gastrointestinal; HLOS: hospital length of stay; US ARC: United States aortic research consortium; PRA:
pararenal aortic aneurysm; CAAA: complex abdominal aortic aneurysm. Categorical variables are presented as numbers (percent) or (percentage). Continuous variables are presented as mean (± standard
deviation) or median (range).
Results on open surgery repair were also analyzed by Coselli et al. . Out of 3,309 open repairs included in the study, there were 1,864 late deaths . Estimated
[19]
[19]
survival was 83.5% ± 0.7% at 1 year, 63.6% ± 0.9% at 5 years, 36.8% ± 1.0% at 10 years, and 18.3% ± 0.9% at 15 years.
CONCLUSION
Endovascular treatment of TAAA has evolved widely and gained widespread acceptance due to reduced morbidity and mortality compared to open repair.
Formerly reserved to treat high-risk patients, its indications are currently broadened and include young patients with suitable anatomy. Meticulous surgical
planning, appropriate patient and device selection, and precise implantation technique are key to achieving optimal outcomes. Finally, technological
advancements continue to develop rapidly, favoring better outcomes and expanding indications for this modality of repair.